Abstract:BACKGROUND:The positive rate of human leucocyte antigen(HLA)-B27 in the patient with ankylosing spondylitis(AS) has significant differences among different reports,which might be induced by environment but also could be affected by other HLA or non-HIL factors.It is presumed that some other factors might play certain roles in the genesis of AS. OBJECTIVE:To investigate the correlation between the polymorphism in the promoter region of tumor necrosis factor(TNF α ) and AS. DESIGN:A non-randomised controlled trial. SETTING and PARTICIPANTS:Data collection setting:United Hospital Affiliated to Tongji Medical University.Participants:Totally 78 AS cases were selected from Wuhan Region during June 2000 to January 2003,who were in accordance with diagnostic criteria modified by Van der Linder in 1984,including 67 males and 11 females,of which the mean age was(37.4± 12.8) years old.52 HLA-B27 positive healthy Wuhan citizens,who were the Han nationality were selected in control group, which included 44 male and 8 female subjects with a mean age of(39.2± 14.4) years old. INTERVENTIONS:A Nco I restrictive site polymorphism in the promoter region of the TNF gene was detected by polymerase chain reaction-restriction fragment length polymorphisms(PCR-RFLP) in both 78 patients with AS and 52 HLA-B27 positive healthy controls.Meanwhile,enzyme linked immunosorbent assay(ELISA) was used to assay serum TNF α level in both patients and controls. MAIN OUTCOME MEASURES:The relationship between the genotype of -308 promoter region of TNF gene and AS. RESULTS:The -308.1.1 genotype was found in 61/78(78.2% ) AS patients,which was significantly higher compared with 29/52(55.8% ) of HLA-B27 positive healthy subjects(χ 2=6.8,P< 0.05).The -308.1.2 and -308.2.2 genotypes in AS patients were 20% and 1% respectively,which were significantly lower than 38% (χ 2=9.3,P< 0.05) and 5.8% (χ 2=11.4,P< 0.01).The levels of serum TNF α [(15.80± 11.20) and 28.00 μ g/L] and C reactive protein[(44.1± 26.3) and 105.3 ng/L],erythrocyte sedimentation rate(ESR)[(27.7± 11.5) and 61.5 mm per hour] and immunoglobulin A[(33.5± 19.7) and 29.2 g/L] in the AS patients with the latter two genotypes were significantly higher than that of AS patients with -308.1.1 genotype(t=3.5,2.1,3.1,P< 0.05- 0.01). CONCLUSION:The -308.1 allele is more common in patients with AS than in HLA-B27 positive normal controls,which implies that the polymorphism in this region of TNF gene is correlated with AS.

Analysis of the clinical value of the expression and immune function of HLA-B27 antigen in the patients with ankylosing spongylitis

Comparative study of three measurement methods for the determination of HLA-B27 antigen in ankylosing spondylitis patient

Significance and Detection of Expression on HLA-B27 Antigen by Flow Cytometry:Comparison of Microlymphocytotoxicity Test

The Relationship of the Subtypes of HLA-B27,HLA-Cw and KIRs with the Activity of Ankylosing Spondylitis

Investigation of the Relationship Between Ankylosing Spondylitis and HLA-B27 in Hunan Province

Comparison of Results of Detection of HLA-B27 Antigen by Flow Cytometry and RT-PCR

High Frequencies of Hla-B27 in Chinese Patients with Suspected of Ankylosing Spondylitis

The immune dysfunction in ankylosing spondylitis patients.

Analysis on the Expression of Toll-like Receptor 4 Mrna in Peripheral Blood Mononuclear Cells from the Patients with Ankylosing Spondylitis and Rheumatoid Arthritis and Its Clinical Significance

Role of HLA-B27 in the Pathogenesis of Ankylosing Spondylitis

The Expression and Significance of CD28, Ctla-4, CD80 and CD86 in Ankylosing Spondylitis Were Also Stimulated

Hypothetic verification of the correlation between polymorphism in the promoter region-308 of the tumor necrosis factor gene and ankylosing spondylitis

Systematic Identification and Comparative Analysis of Human Cartilage-Derived Self-peptides Presented Differently by Ankylosing Spondylitis (As)-Associated HLA-B27:05 and Non-AS-associated HLA-B27:09

Polymorphisms of KIR Gene and HLA-C Alleles: Possible Association with Susceptibility to HLA-B27-Positive Patients with Ankylosing Spondylitis

Distinct MHC Class I and Class II Alleles in Taiwanese Patients with Ankylosing Spondylitis

Clinical Significace of HLA-B27 Detection in Patients with Un-definition Rheumatic Diseases

Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis

Elevated Serum Level of IL-27 and VEGF in Patients with Ankylosing Spondylitis and Associate with Disease Activity

Clinical analysis of 97 patients with ankylosing spondylitis

The Role of CD4+CD25high Regulatory T Cells in the Pathogenesis of Ankylosing Spondylitis

Analysis on Serum Level of Soluble TNF-related Apoptosis-inducing Ligand in Patients with Ankylosing Spondylitis and Its Clinical Significance